Pituitary

Article	Citations
A comparison of macular ganglion cell and retinal nerve fibre layer optical coherence tomographic parameters as predictors of visual outcomes of surgery for pituitary tumours	153
Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life	51
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours	50
Correction to: Osilodrostat improves blood pressure and glycemic control in patients with Cushing’s disease: a pooled analysis of LINC 3 and LINC 4 studies	42
Prevalence and risk factors of colon polyps and other colonic lesions in acromegaly: Insights from colonoscopy screening	39
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency	38
Neuromedin B receptor as a potential therapeutic target for corticotroph adenomas	36
The impact of facility type and volume on treatment and overall survival in craniopharyngioma	34
Substance P and Neurokinin-1 receptor are overexpressed in adamantinomatous craniopharyngioma than in the pituitary gland	31
Predictors of biochemical remission after transsphenoidal surgery in a large cohort of acromegaly patients	29
Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient survey	27
Pituitary: hic manebimus optime	26
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study	26
Complications and mortality of Cushing’s disease: report on data collected over a 20-year period at a referral centre	24
Gigantism: microsurgical treatment by transsphenoidal approach and prognostic factors	24
ACRODAT and SAGIT for the assessment of disease activity in acromegaly: a multicenter study of the Veneto region in Italy	23
The assessment of thiol-disulfide homeostasis and ıschemia-modified albumin levels in patients with acromegaly	22
Efficacy and safety of once-weekly somatrogon in adults with growth hormone deficiency: a randomized phase 3 study	20
Genetic models of Cushing’s disease	20
Non-written guidelines in pituitary tumor surgery. The hidden curriculum	20
Basal cortisol in relation to metyrapone confirmation in predicting adrenal insufficiency after pituitary surgery	20
Acromegaly increases depressive symptoms and reduces quality of life of cohabitants	20
Sleep disruption in patients with active and treated endogenous Cushing’s syndrome	18
Psychological profiles of patients with acromegaly: personality traits, quality of life, and clinical correlates	18
The efficacy of minimally invasive intraoperative ultrasound in endoscopic pituitary surgery	18

Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria	18
Implementation of functional imaging using 11C-methionine PET-CT co-registered with MRI for advanced surgical planning and decision making in prolactinoma surgery	18
Pituitary metastases: a case series and scoping review	18
Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas	18
Psychiatric morbidity in acromegaly: a cohort study and meta-analysis of the literature	17
Consensus on acromegaly complications: an update	17
Correction: Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	17
Bone health and skeletal fragility in second- and third-line medical therapies for acromegaly: preliminary results from a pilot single center experience	17
Pituitary surgery in Cushing’s disease: first line treatment and role of reoperation	16
Shared decision-making and detection of comorbidities in an online acromegaly consultation with and without the Acromegaly Disease Activity Tool ACRODAT® using the simulated person approach	16
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors	16
Diagnosis of growth hormone deficiency: searching for Consensus along life	16
Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes	16
How to rule out non-neoplastic hypercortisolemia (previously known as pseudo-cushing)	15
TSH-secreting pituitary adenomas and bone	14
The diagnosis and prevalence of hypoprolactinemia in patients with panhypopituitarism and the effects on depression and sexual functions	14
Diagnostic performance of desmopressin stimulation test in pediatric cushing’s disease	14
Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs)	14
Commentary: The updated European society of endocrinology clinical practice guideline for the management of aggressive pituitary tumors and pituitary carcinomas	14
IGF-1 is positively associated with BMI in patients with acromegaly	14
Response to letter to the editor “Hypopituitarism and COVID-19, what else?”	14
Cushing’s disease and bone	14
A post-hoc internal validation of arginine-stimulated copeptin cut-offs for diagnosing AVP deficiency (central diabetes insipidus)	14
From misclassified AIP variant to carney complex: a case report and retrospective evaluation of PRKAR1A in pituitary tumor predisposition	13
Pituitary surgery and COVID	13
Development and validation of clinical screening systems for Cushing disease in the United States	13
Outcomes in surgical management of microprolactinomas: an international multi-institutional series	13
The impact of growth hormone (GH) on immunosenescence: exploring the role of B and T cells	13
Circadian rhythm proteins as potential biomarkers in pituitary adenomas: an immunohistochemical analysis	13
Clinical, surgical, and endocrine outcome following treatment of posterior pituitary tumors: a retrospective cohort study	13
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study	13
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly	13
Reappraising prediction of surgical complexity of non-functioning pituitary adenomas after transsphenoidal surgery: the modified TRANSSPHER grade	13
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation	13
Is diabetes with acromegaly for life?	12
Mortality in patients with dopamine agonist-treated hyperprolactinemia: a large matched-cohort study	12
Long COVID and pituitary dysfunctions: a bidirectional relationship?	12
Copeptin after pituitary surgery: is it worth measuring?	12
Serum biomarkers of colonic polyps in patients with acromegaly: a meta-analysis and systematic review	12
[68 Ga]-DOTATATE PET/MR-based evaluation of physiologic somatostatin receptor 2 expression in the adult pituitary gland as a function of age and sex in a prospective cohort	11
Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly	11
Anemia in acromegaly: Prevalence, etiologies, and predictors from a large tertiary center cohort	11
Validation and modification of the PANOMEN 3 classification for predicting long-term recurrence/progression and quality of life in patients with pituitary adenomas: a multicentre retrospective cohort	11
SAGIT®, ACRODAT®, PANOMEN 3… time to implement tools for management of acromegaly..?	11
Cabergoline treatment for surgery-naïve non-functioning pituitary macroadenomas	11
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience	11
The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: a real-world retrospective single center study of a surgically treated cohort	11
Nelson’s syndrome: reappraisal of an uncommon disease	10
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults	10
Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis	10

Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery – a prospective study	10
Usefulness of a clinicopathological classification in predicting treatment-related outcomes and multimodal therapeutic approaches in pituitary adenoma patients: retrospective analysis on a Portuguese	10
Serum IGF-1 May be less reliable when assessing the GH-IGF-1 axis in the elderly	10
Refractory nonfunctioning pituitary adenomas	10
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis	10
Skeletal fragility in pituitary disease: how can we predict fracture risk?	9
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma	9
Surgical treatment of cystic pituitary adenomas: literature-based definitions and postoperative outcomes	9
Proportion and predictors of Hypogonadism Recovery in Men with Macroprolactinomas treated with dopamine agonists	9
Genetic evaluation of pediatric pituitary adenomas and USP8-related genotype-phenotype correlations in Cushing’s disease	9
Diffusion-weighted imaging does not seem to be a predictor of consistency in pituitary adenomas	9
Growth hormone insensitivity and adipose tissue: tissue morphology and transcriptome analyses in pigs and humans	9
Effect of antineoplastic drug therapies on carcinoma and aggressive pituitary tumors: a systematic review and meta-analysis	9
Outcomes of stereotactic radiosurgery in nelson’s syndrome: a systematic review and Meta-Analysis	9
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon	9
Measuring pituitary tumor volume: a comparison of the simplified and non-simplified ellipsoid equation with the 3D planimetric volume assessment	9
Importance of 24 h ambulatory blood pressure monitoring in patients with acromegaly and correlation with cardiac magnetic resonance findings	8
Alert: misinformation that may hurt patients with both adrenal insufficiency and AVP deficiency	8
The diagnosis of GH deficiency in adult β-thalassemic patients: are two different stimulation tests necessary to improve specificity?	8
The somatotroph pituitary gland function in high-aged multimorbid hospitalized patients with IGF-I deficiency	8
A Retrospective cohort study of Knosp grade reporting of cavernous sinus invasion in pituitary macroadenomas	8
The effect of growth hormone replacement therapy on craniopharyngioma recurrence: a systematic review and meta-analysis	8
Giant prolactinomas, a detailed analysis of 196 adult cases	8
Changes in pituitary adenoma patient presentation and outcomes during the COVID pandemic at a Pituitary Center of Excellence	8
Pituitary stalk biopsy – A systematic review of the safety and efficacy of stalk lesion biopsy	8
Posterior hypothalamic involvement on pre-operative MRI predicts hypothalamic obesity in craniopharyngiomas	8
An update on, and genetics of refractory adenomas of childhood	7
High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma	7
Surgical management in very elderly patients with pituitary adenoma: a multivariable assessment of the surveillance, epidemiology, and end results database	7
Postoperative weight gain following endoscopic endonasal surgery for craniopharyngiomas in children and adults: A retrospective cohort study	7
Pregnancy and delivery after surgical remission in women with prolactinomas desiring pregnancy: Refining surgical indications	7
Cushing’s disease: role of preoperative and primary medical therapy	7
Can we predict the risk of venous thromboembolism in patients with Cushing’s syndrome: a nationwide cohort analysis	7
The comprehensive evaluation of oral and fecal microbiota in patients with acromegaly	7
How to manage intolerance to dopamine agonist in patients with prolactinoma	7
Cushing’s syndrome: Guidance on thromboprophylaxis at last	7
TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours	7
HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency	7
Correction: consensus on criteria for acromegaly diagnosis and remission	7
Clinical use of [18F]fluoro-ethyl-L-tyrosine PET co-registered with MRI for localizing prolactinoma remnants	7
Glucose metabolism, gut-brain hormones, and acromegaly treatment: an explorative single centre descriptive analysis	7
Correction: Impulse control disorders in patients with dopamine agonist-treated pituitary adenomas: a cross-sectional multicenter study	6
Sex differences in the clinical presentation, management and long-term outcomes of pituitary tumors in children and adolescents	6
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in Japan	6
Selective resection of the medial wall of the cavernous sinus in pituitary surgery: results of a prospective single center analysis	6
Cushing’s syndrome and COVID-19	6
Pituitary enlargement in patients with cerebrospinal fluid drainage due to ventricular shunt insertion: know the condition and do not mistake for adenoma	6
Pituitary acting drugs: cabergoline and pasireotide	6
Syndrome of inappropriate antidiuresis/hyponatremia in COVID-19	6
Critical views for safe surgical phase progression in endoscopic endonasal transsphenoidal pituitary adenoma resection: modified Delphi consensus	6
Non-penetrant Xq26.3 duplication involving the invariant TAD border: clinical evidence for the VGLL1 region as the GPR101 pituitary enhancer of X-linked acrogigantism	6
Sellar and perisellar meningiomas: effects on pituitary function in a Spanish cohort observational study	6
Clinico-radiological correlation of pituitary stalk interruption syndrome in children with growth hormone deficiency	6
Patients with langerhans cell histiocytosis and hypothalamic-pituitary involvement: insights from the HEROS study cohort	6
Pituitary Tumor Centers of Excellence (PTCOE) should now include neuro-oncologic input	6
Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease	6
Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review	6
Old and new pituitary biomarkers: evidence for sex-specificity	6
Impulse control disorders in patients with pituitary adenoma managed with or without dopamine agonists: a cross-sectional study from a UK centre	6
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center	6
Letter to the editor regarding “Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature”	5
Metastases to the pituitary gland: insights from the German pituitary tumor registry	5
Posterior pituitary tumors: an entity unto itself	5
The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases	5
Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis	5
GHR disruption in mature adult mice alters xenobiotic metabolism gene expression in the liver	5
Age and hematologic parameters can predict prolonged glucocorticoid replacement after remission of cushing disease and adrenal Cushing’s syndrome: A nationwide cohort study	5
Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus	5
Elevated risk of recurrence and retreatment for silent pituitary adenomas	5
Novel imaging techniques in refractory pituitary adenomas	5
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center	5
Refractory Pit1 plurihormonal tumours and thyrotroph adenomas	5
Vitamin D in pituitary driven osteopathies	5
Preoperative differentiation of hypophysitis and pituitary adenomas using a novel clinicoradiologic scoring system	5
Estimation of the biological variation of IGF-I in multimorbid geriatric patients and its clinical implications	5
Cushing’s disease in children: unique features and update on genetics	5
Exercise ventilatory inefficiency may be a specific feature of patients with acromegaly	5
Craniopharyngioma – What’s next	5
Role of Radiation in the treatment of Cushing Disease	5
Biochemical and metabolic tissue discrimination using a dual-modality Raman-fluorescence endonasal spectroscopy probe for pituitary adenoma surgery	5

Exploring the role of the tumor microenvironment in refractory pituitary tumor pathogenesis	5
Endoscopic endonasal transcavernous surgery for a contemporary series of 59 prolactinomas	5
Care trajectories of surgically treated patients with a prolactinoma: why did they opt for surgery?	4
High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors	4
Kidney function in acromegaly: evidence from a long-term observational study	4
Response to letter to the editor “proposed consideration for targeted immunotherapy in pituitary carcinomas and aggressive pituitary tumors”	4
Gender differences in surgical outcomes and predictors of long term endocrine and metabolic morbidity in adults with craniopharyngioma	4
Cushing’s disease: adrenal steroidogenesis inhibitors	4
Letter to the editor: Pituitary hyperplasia causing visual symptoms in a young woman planning pregnancy	4
Dabrafenib as a diagnostic and therapeutic strategy for the non-surgical management of papillary craniopharyngioma	4
Cardiovascular and metabolic outcomes of GH replacement therapy in adults with GH deficiency – gender gaps	4
Glucose intolerance in acromegaly is driven by low insulin secretion; results from an intravenous glucose tolerance test	4
Enhancing diagnostic tools for vasopressin deficiency: insights from a single-center cohort study	4
Urinary incontinence as a novel and underrecognized clinical manifestation of prolactinoma in women	4
Sleep quality in patients with non-functioning pituitary adenoma: impact of replacement therapies with an emphasis on the time of hydrocortisone	4
11C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy	4
Long-term cabergoline use does not predict degree of prolactinoma fibrosis nor significantly impact surgical outcomes	4
Exploring sex-specific hematological changes and their impact on quality of life in patients with prolactinoma	4
Hypopituitarism and COVID-19	4
Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists	4
Precocious puberty, pandemic and beyond	4
Reported outcomes in transsphenoidal surgery for pituitary adenomas: a systematic review	4
The efficacy of a visiting surgical service versus that of a hospital-based surgical service in providing endoscopic endonasal surgery to remove nonfunctioning pituitary adenomas in rural communities	4
Clinical characteristics, surgical and endocrinological outcomes of sellar and parasellar masses in pediatric patients: a single-center experience	4
Epigenetic implications in the pathogenesis of corticotroph tumors	4
Clinicopathological analysis of non-functioning pituitary adenomas (PAs) according to the 2022 WHO classification	4
Sheehan syndrome: a current approach to a dormant disease	4
Predictive factors for post-therapeutic biochemical discordance in acromegaly: a monocentric analysis of 156 cases	4
A patient-reported outcome measure for patients with pituitary adenoma undergoing transsphenoidal surgery	4
Treatment of recurrent and persistent Cushing’s disease after first transsphenoidal surgery: lessons learned from an international meta-analysis	4
Morphometric study of the pituitary gland and stalk with emphasis on lifestyle factors	4
Clinical and imaging findings for the evaluation of large Rathke’s cleft cysts and cystic craniopharyngiomas	4
Impact of sex on mortality in patients with pituitary adenomas	4
Changing the name of diabetes insipidus	4
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience	4
Somapacitan-induced reversible lipoatrophy in an adult woman with hypopituitarism	4
“Intrasellar tumor-to-tumor metastasis: A single center experience with a systematic review”	4
Correction: Giant prolactinomas, a detailed analysis of 196 adult cases	4
To test or not to test: what we have learnt from 50 years of dynamic testing in acromegaly	4
Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing’s syndrome: a large population database study	4
Two-stage surgery for cystic craniopharyngiomas: a purely endoscopic strategy and outcomes	3
Surgical strategies in the treatment of MR-negative Cushing’s Disease: a systematic review and treatment algorithm	3
FGFR1 variation in the divergent settings of congenital hypopituitarism and pituitary tumours	3
Cushing’s disease: risk of recurrence following trans-sphenoidal surgery, timing and methods for evaluation	3
The spectrum of cardiac abnormalities in patients with acromegaly: results from a case-control cardiac magnetic resonance study	3
Neuroendocrine challenges and clinical outcomes in men with chronic traumatic brain injury: a cross-sectional study	3
Anterior-posterior diameter is a key driver of resectability and complications for pituitary adenomas with suprasellar extension in endoscopic transsphenoidal surgery	3
Newer parameters of the octreotide test in patients with acromegaly	3
Post-operative surveillance for somatotroph, lactotroph and non-functional pituitary adenomas after curative resection: a systematic review	3
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)	3
Impact of granulation pattern on surgical and long-term outcomes in Cushing’s disease: a comparative study of DGCT and SGCT	3
Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH research society	3
Efficacy and safety of pasireotide treatment in acromegaly: A systematic review and single arm meta-analysis	3
Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS)	3
External validation of the PANOMEN-3 classification for predicting 1-year surgical remission in pituitary adenoma	3
A procedure in mice to obtain intact pituitary-infundibulum-hypothalamus preparations: a method to evaluate the reconstruction of hypothalamohypophyseal system	3
Diagnostic, therapeutic, and prognostic characteristics of patients with acromegaly according to tumor size at diagnosis	3
Contemporary radiotherapy and radiosurgery techniques for refractory pituitary adenomas	3
Pituitary hypophysitis in granulomatosis with polyangiitis (GPA): a case series	3
Role of biological effective dose for prediction of endocrine remission in acromegaly patients treated with stereotactic radiosurgery	3
Intranasal povidone-iodine concentration and olfactory recovery after endoscopic endonasal pituitary surgery	3
Long-term efficacy and safety of osilodrostat in Cushing’s disease: final results from a Phase II study with an optional extension phase (LINC 2)	3
Impact of nasal septal deviation on surgical outcomes in endoscopic transsphenoidal surgery: a population-based study	3
Development and validation of a novel treatment adherence, satisfaction and knowledge questionnaire (TASK-Q) for adult patients with hypothalamic-pituitary disorders	3
Correlates of prolonged length of stay after endoscopic transsphenoidal surgery for pituitary adenomas: varying definitions and non-clinical factors	3
Giant prolactinoma in children and adolescents: a single-center experience and systematic review	3
Management of hypopituitarism during pregnancy in patients with PROP1-related combined pituitary hormone deficiency: Review of the literature with a case report	3
Temporal and masseter muscle evaluation by MRI provides information on muscle mass and quality in acromegaly patients	3
Standardizing blood pressure phenotyping in acromegaly: A practical companion to Araujo-Castro et al.	3
Advances in surgical approaches for refractory pituitary adenomas	3
Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases	3
Current status of artificial intelligence technologies in pituitary adenoma surgery: a scoping review	3
Impact of insurance on outcomes of patients undergoing endoscopic transsphenoidal surgery for non-functional pituitary adenomas: a single institution study	3
Differential diagnosis between Cushing’s syndrome and non-neoplastic hypercortisolism: are we getting there?	3
Repeat endoscopic endonasal transsphenoidal surgery for residual or recurrent Cushing’s disease: safety, feasibility, and success	3